Emergen logo.png
How Will the Neurodiagnostics Market Transform Itself into a USD 14.83 Billion Powerhouse by 2032?
August 10, 2023 10:19 ET | Emergen Research
Vancouver, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential...
logo-alt.png
Neurodiagnostics Market accounted for US$ 7.22 billion in 2022 and is estimated to be US$ 17.8 billion by 2032 and is anticipated to register a CAGR of 11.8% - By PMI
December 12, 2022 09:02 ET | PMI
Covina, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Neurodiagnostics is the study of brain in which it records activity of brain & central nervous system to evaluate if it functions correctly. Various...
Heart Pump Device Market Size and Upcoming Technological Innovations Will Boom in 2022-2028 | Analyzed by Size Share, Trends, Key Players & Future Growth Outlook
September 08, 2022 03:13 ET | Exactitude Consultancy
Luton, Bedfordshire, United Kingdom, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has...
AMR Logo.png
Global Neurodiagnostics Market Size to Surpass $12.89 Billion by 2030; IVD segment Would Cite the Fastest CAGR of 7.8%
August 17, 2021 09:41 ET | Allied Market Research
Portland, OR, Aug. 17, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Neurodiagnostics Market was estimated at $6.53 billion in 2020 and is expected...
Reports and Data.jpeg-01
Neurodiagnostics Market To Reach USD 25.14 Billion By 2026 | Reports And Data
November 26, 2019 10:24 ET | Reports and Data
New york, Nov. 26, 2019 (GLOBE NEWSWIRE) -- High prevalence of neurological disorders, adoption of novel diagnostic technology, product launches, increasing strategic developments such as...
Reports and Data.jpeg-01
Neurodiagnostics Market To Reach USD 25.14 Billion By 2026 | Reports And Data
November 26, 2019 10:24 ET | Reports and Data
New york, Nov. 26, 2019 (GLOBE NEWSWIRE) -- High prevalence of neurological disorders, adoption of novel diagnostic technology, product launches, increasing strategic developments such as...